Live data from Hacker News

Ozempic increases risk of debilitating eye condition: studies

sdu.dk

1–10 of 107 posts

Re: Ozempic increases risk of debilitating eye condition: studies

#3
Important to note that this side effect is still very rare and that we still use drugs with similarly serious and rare side effects.

The authors of the study do not recommend abandoning these drugs, rather we should understand and manage the risks.

Re: Ozempic increases risk of debilitating eye condition: studies

#7

Important to note that this side effect is still very rare and that we still use drugs with similarly serious and rare side effects. The authors of the study do not recommend abandoning these drugs, rather we should understand and manage the risks.

Doesn't untreated diabetes also cause blindness in some people? definitely seems better to take it than not.

Re: Ozempic increases risk of debilitating eye condition: studies

#8
> Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the optic nerve of the eye [NAION], which can lead to severe and permanent loss of vision.

> The condition [NAION] is often developed by patients who are at particular risk of cardiovascular disease. The risk factors are diabetes, high blood pressure and high cholesterol. Patients affected by the condition also tend to have some physical conditions in the eye, which can be the triggering factor.

Re: Ozempic increases risk of debilitating eye condition: studies

#9
If you literally cannot stop yourself from being obese any other way, then Ozempic and similar may be a good choice.

But the side effects are large. You can never, ever stop taking it. We don't know what being on it for decades causes. There are anecdotes that it numbs you out emotionally.

There are no shortcuts in life. There is always a tradeoff.

Re: Ozempic increases risk of debilitating eye condition: studies

#10

in patients with Type 2 diabetes

this part was both clear and unclear to me - does it exclude patients using it for weight loss or not?

They didn't study patients using semaglutide for weight loss only.

I guess a Bayesian would increase their estimated probability of such a problem also for the weight loss case, but not by as much (as diabetes predisposes people to other ailments).

Post reply on HN